The team focus on breakthrough therapies and platforms, deep science transforming human health, across all therapy areas and modalities.

Tackling the world’s most urgent and complex diseases – from cancer and autoimmune conditions to neurodegeneration and vision loss.

Synthetic biology, antibody engineering, and other platform technologies unlocking new therapies and accelerating discovery.

Tools for stratifying patients, identifying biomarkers, and targeting treatment – reshaping how we understand and treat disease.
From reprogramming immune cells to restoring sight, our companies are redefining what’s possible in human health.